Scholarlink

<p>Intracerebral hemorrhage (ICH) has poor clinical outcomes, with microglia-induced neuroinflammation being a key pathological process. This study investigated the therapeutic potential of ectomesenchymal stem cells (EMSCs) from the nasal mucosa in ICH. Using a mouse ICH model, we transplanted EMSCs intracranially. We assessed neurological function, neuronal survival, microglial polarization, and inflammatory responses. In vitro, we co-cultured EMSCs with hemin-stimulated microglia and performed transcriptomic analysis. Key proteins in the NF-κB and MAPK pathways were evaluated in vivo based on in vitro findings. EMSC transplantation significantly improved neurological deficits and reduced neuronal injury. It promoted microglial polarization towards the anti-inflammatory M2 phenotype and increased levels of the anti-inflammatory cytokine IL-10. Mechanistically, EMSCs suppressed the activation of the NF-κB and MAPK signaling pathways in microglia. Our findings demonstrate that EMSCs alleviate neuroinflammation and neural injury after ICH by modulating microglial polarization, potentially via inhibiting the NF-κB and MAPK pathways. This suggests EMSCs as a promising novel therapy for hemorrhagic stroke.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ectomesenchymal Stem Cell Transplantation Induces Microglial Polarization and Anti-inflammatory IL-10 Secretion via NF-κB and MAPK Pathways to Mitigate Brain Injury Post-cerebral Hemorrhage

  • 期刊论文

  • 发表日期：

    2025年12月20日

查看全文
  • Yilu Li,
  • Wenhui Yang,
  • Yushi Tang,
  • Shiqing Du,
  • Yang Ye,
  • Bai Xu,
  • Wentao Shi,
  • Xudong Zhao,
  • Xiaojie Lu

摘要

Intracerebral hemorrhage (ICH) has poor clinical outcomes, with microglia-induced neuroinflammation being a key pathological process. This study investigated the therapeutic potential of ectomesenchymal stem cells (EMSCs) from the nasal mucosa in ICH. Using a mouse ICH model, we transplanted EMSCs intracranially. We assessed neurological function, neuronal survival, microglial polarization, and inflammatory responses. In vitro, we co-cultured EMSCs with hemin-stimulated microglia and performed transcriptomic analysis. Key proteins in the NF-κB and MAPK pathways were evaluated in vivo based on in vitro findings. EMSC transplantation significantly improved neurological deficits and reduced neuronal injury. It promoted microglial polarization towards the anti-inflammatory M2 phenotype and increased levels of the anti-inflammatory cytokine IL-10. Mechanistically, EMSCs suppressed the activation of the NF-κB and MAPK signaling pathways in microglia. Our findings demonstrate that EMSCs alleviate neuroinflammation and neural injury after ICH by modulating microglial polarization, potentially via inhibiting the NF-κB and MAPK pathways. This suggests EMSCs as a promising novel therapy for hemorrhagic stroke.